Int J Angiol 2017; 26(04): 228-233
DOI: 10.1055/s-0037-1607037
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Usefulness of a Nonsuture Closure Device in Patients Undergoing Diagnostic Coronary and Peripheral Angiography

John T. Owens
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
,
Shaun Bhatty
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
,
Robert J. Donovan
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
,
Andrea Tordini
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
,
Peter Danyi
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
,
Kalpesh Patel
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
,
Jacob A. Wegelin
2   Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia
,
Ion S. Jovin
1   Department of Medicine, McGuire VA Medical Center, Virginia Commonwealth University, Richmond, Virginia
› Author Affiliations
Further Information

Publication History

Publication Date:
04 October 2017 (online)

Abstract

Vascular access site complications can follow diagnostic coronary and peripheral angiography. We compared the complication rates of the Catalyst vascular closure device, with the complication rates after manual compression in patients undergoing diagnostic angiographic procedures via femoral access. We studied 1,470 predominantly male patients undergoing diagnostic coronary and peripheral angiography. Catalyst closure devices were used in 436 (29.7%) patients and manual compression was used in 1,034 (70.3%) patients. The former were allowed to ambulate after 2 hours, while the latter were allowed to ambulate after 6 hours. Major complications occurred in 4 (0.9%) patients who had a Catalyst device and in 14 (1.4%) patients who had manual compression (odds ratio [OR]: 0.67, 95% confidence interval [CI]: 0.22–2.1, p = 0.49). Any complications occurred in 51 (11.7%) patients who had a Catalyst closure device and in 64 (6.2%) patients who had manual compression (OR: 2, CI: 1.4–3, p < 0.01). After adjustment for other variables and for a propensity score reflecting the probability to receive the closure device, the association of major complications with the use of the closure device remained not significant (OR: 0.54, 95% CI: 0.17–1.7, p = 0.29), while the association of any complications with the use of the Catalyst device remained significant (OR: 1.9, 95% CI: 1.3–2.9, p < 0.01). The Catalyst device was not associated with an increased risk of major groin complications but was associated with an increased risk of any complications compared with manual compression. Patients receiving the closure device ambulated sooner.

 
  • References

  • 1 Bhatty S, Cooke R, Shetty R, Jovin IS. Femoral vascular access-site complications in the cardiac catheterization laboratory: diagnosis and management. Interv Cardiol (London) 2011; 3 (04) 503-514
  • 2 Chandrasekar B, Doucet S, Bilodeau L. , et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv 2001; 52 (03) 289-295
  • 3 Nasser TK, Mohler III ER, Wilensky RL, Hathaway DR. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 1995; 18 (11) 609-614
  • 4 Messina LM, Brothers TE, Wakefield TW. , et al. Clinical characteristics and surgical management of vascular complications in patients undergoing cardiac catheterization: interventional versus diagnostic procedures. J Vasc Surg 1991; 13 (05) 593-600
  • 5 Ricci MA, Trevisani GT, Pilcher DB. Vascular complications of cardiac catheterization. Am J Surg 1994; 167 (04) 375-378
  • 6 Stegemann E, Hoffmann R, Marso S, Stegemann B, Marx N, Lauer T. The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization. Clin Res Cardiol 2011; 100 (09) 789-795
  • 7 Omoigui NA, Califf RM, Pieper K. , et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). J Am Coll Cardiol 1995; 26 (04) 922-930
  • 8 McCabe PJ, McPherson LA, Lohse CM, Weaver AL. Evaluation of nursing care after diagnostic coronary angiography. Am J Crit Care 2001; 10 (05) 330-340
  • 9 Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vasc Interv Radiol 2003; 14 (07) 865-885
  • 10 Tordini A, Polkampally PR, Jovin IS. Vascular closure devices in percutaneous coronary and peripheral interventions: rationale and results. Interv Cardiol (London) 2012; 3 (05) 569-576
  • 11 Doyle BJ, Godfrey MJ, Lennon RJ. , et al. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization. Catheter Cardiovasc Interv 2007; 69 (02) 203-208
  • 12 Foran JP, Patel D, Brookes J, Wainwright RJ. Early mobilisation after percutaneous cardiac catheterisation using collagen plug (VasoSeal) haemostasis. Br Heart J 1993; 69 (05) 424-429
  • 13 Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993; 22 (05) 1273-1279
  • 14 Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 2004; 291 (03) 350-357
  • 15 Kiesz RS, Wiernek BK, Wiernek SL. , et al. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial). J Endovasc Ther 2011; 18 (01) 46-53
  • 16 Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J 2007; 153 (04) 606-611
  • 17 Ward SR, Casale P, Raymond R, Kussmaul III WG, Simpfendorfer C. ; Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol 1998; 81 (05) 569-572
  • 18 Baim DS, Knopf WD, Hinohara T. , et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 2000; 85 (07) 864-869
  • 19 Schulz-Schüpke S, Helde S, Gewalt S. , et al; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA 2014; 312 (19) 1981-1987
  • 20 Crocker CH, Cragun KT, Timimi FK. , et al. Immediate ambulation following diagnostic coronary angiography procedures utilizing a vascular closure device (The Closer). J Invasive Cardiol 2002; 14 (12) 728-732